Abstract:Objective: To elucidate the potential causality of leukocyte telomere length (LTL) with immune-mediated inflammatory diseases (IMIDs), we conducted a Mendelian randomization (MR) study. Methods: The genetically predicted causation between LTL and IMIDs was evaluated using a two-sample MR method. We analyzed 16 major IMIDs, which included systemic lupus erythematosus (SLE), inflammatory bowel disease (IBD), ulcerative colitis (UC), Crohn's disease (CD), ankylosing spondylitis (AS), sicca syndrome (SS), rheumatoid arthritis (RA), type 1 diabetes (T1D), primary sclerosing cholangitis (PSC), idiopathic pulmonary fibrosis (IPF), atopic dermatitis (AD), sarcoidosis, hypothyroidism, hyperthyroidism, psoriasis, and childhood asthma. The random-effects inverse-variance weighted (IVW) method was performed as the main analytical approach in MR. Various sensitivity analyses, including MR-Egger, MR robust adjusted profile score (MR-RAPS), weighted median, MR pleiotropy residual sum and outlier (MR-PRESSO) methods, weighted mode, radial plot, and radial regression, were used to guarantee the robustness of the results and detect horizontal pleiotropy. Cochran's Q value was calculated to check for heterogeneity, and the MR Steiger approach was used to test the causal direction. Results: The MR results indicated significant inverse associations of LTL with risks of psoriasis (OR: 0.77, 95% CI: 0.66–0.89, and p = 3.66 × 10 −4 ), SS (OR: 0.75, CI: 0.58–0.98, and p = 0.03), RA (OR: 0.77, 95% CI: 0.68–0.88, and p = 9.85 × 10 −5 ), hypothyroidism (OR: 0.84, 95% CI: 0.78–0.91, and p = 7,08 × 10 −6 ), hyperthyroidism (OR: 0.60, 95% CI: 0.44–0.83, and p = 1.90 × 10 −3 ), sarcoidosis (OR: 0.67, 95% CI: 0.54–0.83, and p = 2.60 × 10 −4 ), and IPF (OR: 0.41, 95% CI: 0.29–0.58, and p = 4.11 × 10 −7 ) in the FinnGen study. We observed that longer LTL was associated with an increased risk of AS susceptibility (OR: 1.51, 95% CI: 1.18–1.94, and p = 9.66 × 10 −4 ). The results of the IVW method showed no causal relationship between TL and SLE (OR: 0.92, 95% CI: 0.62–1.38, and p = 0.69) in the FinnGen study; however, a significantly positive correlation was shown between LTL and SLE in another larger GWAS (OR: 1.87, 95% CI: 1.37–2.54, and p = 8.01 × 10 −5 ). Conclusion: Our findings reveal that abnormal LTL has the potential to increase the risk of IMIDs. Therefore, it could be treated as a predictor and may provide new potential treatment targets for IMIDs. However, the change of LTL may not be the direct cause of IMIDs. Further studies should aim at the pathogenic mechanism or potential protective effects of LTL in IMIDs.

Genetic susceptibility to chronic diseases leads to heart failure among Europeans: the influence of leukocyte telomere length

Contribution of leukocyte telomere length to major cardiovascular diseases onset: phenotypic and genetic insights from a large-scale genome-wide cross-trait analysis

The associations of leukocyte telomere length and intermediary cardiovascular phenotype with adverse cardiovascular outcomes in the white population

Polygenic basis and biomedical consequences of telomere length variation

Assessing the association of leukocyte telomere length with ankylosing spondylitis and rheumatoid arthritis: A bidirectional Mendelian randomization study

Leukocyte telomere length and attrition in association with disease severity in cystic fibrosis patients

Association Between Leukocyte Telomere Length and Atrial Fibrillation: A Mendelian Randomization Study

Telomere length and aging-related outcomes in humans: A Mendelian randomization study in 261,000 older participants

17-Year Follow-Up of Association Between Telomere Length and All-Cause Mortality, Cardiovascular Mortality in Individuals with Metabolic Syndrome: Results from the NHANES Database Prospective Cohort Study

Immune-mediated inflammatory diseases and leukocyte telomere length: A Mendelian randomization study

Epigenome-wide association study of leukocyte telomere length.

Genetic liability to asthma and risk of cardiovascular diseases: A Mendelian randomization study

Shorter Leukocyte Telomere Length Is Associated with Increased Major Adverse Cardiovascular Events or Mortality in Patients with Essential Hypertension

Causal Relationship Between Atrial Fibrillation and Leukocyte Telomere Length: A Two Sample, Bidirectional Mendelian Randomization Study

A causal relationship between leukocyte telomere length and multiple sclerosis: A Mendelian randomization study

Genomic, phenomic, and geographic associations of leukocyte telomere length in the United States

Phenotypic and genetically predicted leucocyte telomere length and lung cancer risk in the prospective UK Biobank

Association Between Adverse Early Life Factors and Telomere Length in Middle and Late Life

Association between leucocyte telomere length and the risk of atrial fibrillation: An updated systematic review and meta-analysis

Association of TERC and OBFC1 haplotypes with mean leukocyte telomere length and risk for coronary heart disease

Telomere Length and COVID-19 Outcomes: A Two-Sample Bidirectional Mendelian Randomization Study